...
首页> 外文期刊>Orthopaedic Journal of Sports Medicine >Immediate Pain Relief at Time of Corticosteroid Injection for Idiopathic Adhesive Capsulitis as a Predictor of Eventual Outcomes
【24h】

Immediate Pain Relief at Time of Corticosteroid Injection for Idiopathic Adhesive Capsulitis as a Predictor of Eventual Outcomes

机译:在皮质类固醇注射液中针对特发性粘合剂胶囊炎的立即疼痛缓解作为最终结果的预测因素

获取原文

摘要

Background: Corticosteroid injection and physical therapy remain the mainstay of treatment for idiopathic adhesive capsulitis of the shoulder; however, a certain percentage of patients will not improve using these interventions and will require manipulation under anesthesia (MUA) and/or lysis of adhesions (LOA). Purpose: To evaluate whether the immediate pain reduction after fluoroscopic-guided, mixed anesthetic-corticosteroid injection for idiopathic adhesive capsulitis is related to the eventual need for LOA/MUA or a repeat glenohumeral steroid injection. Study Design: Case-control study; Level of evidence, 3. Methods: This single-institution study involved patients undergoing fluoroscopic glenohumeral corticosteroid injection for a diagnosis of idiopathic adhesive capsulitis between 2010 and 2017. Included were patients with a minimum of 1-year postinjection follow-up and visual analog scale (VAS) pain scores from immediately before and after the injection. The primary analysis was the relationship between patients with an immediate change in VAS score after injection and those who underwent LOA/MUA. A repeat glenohumeral injection was also evaluated as an outcome. Receiver operator characteristic curves and a multivariate binomial logistic regression analysis were performed. Results: Overall, 739 shoulders in 728 patients (mean age, 52.6 years; 68% women) were included, of which 38 (5.1%) underwent LOA/MUA and 209 (28%) underwent repeat injections. The immediate change in the VAS score was not significantly associated with the eventual need for LOA/MUA. Preinjection VAS and immediate postinjection VAS scores were not significant predictors of eventual LOA/MUA or subsequent injection. For all 3 predictors, the area under the receiver operator characteristic curve classified them as extremely poor discriminators. Conclusion: The immediate pain response to a fluoroscopic-guided glenohumeral injection for idiopathic shoulder adhesive capsulitis was not predictive of the eventual need for LOA/MUA or subsequent injection. Patients can be counseled that even if their initial pain response to an injection is poor, they still have an excellent chance of avoiding surgery, as the overall rate of LOA/MUA was low (5.1%).
机译:背景:皮质类固醇注射和物理治疗仍然是肩部特发性粘合剂胶囊炎的治疗方法;然而,一定比例的患者不会使用这些干预措施改善,并且需要在麻醉(MUA)和/或粘连裂解下操纵(LOA)。目的:为了评估荧光镜引导后立即疼痛的疼痛还原,用于特发性粘合剂胶囊的混合麻醉剂 - 皮质类固醇注射液与LOA / MUA的最终需要或重复Glenohumalal类固醇注射有关。研究设计:案例控制研究;证据水平,3.方法:该单机制研究涉及到2010年至2017年间发作性粘合剂囊炎的患者进行荧光型胶质肿瘤皮质类固醇膜质注射症。包括至少1年的患病患者的患者患者患者患者(VAS)疼痛在注射之前和之后立即得分。初步分析是患者在注射后立即变化的患者的关系以及接受LOA / MUA的人。还评估重复的胶质形状注射剂作为结果。进行接收器操作员特征曲线和多变量二项式逻辑回归分析。结果:总体而言,739名患者中的739名肩部(平均年龄,52.6岁; 68%的女性),其中38(5.1%)接受了LOA / MUA和209(28%)进行了重复注射。 VAS分数的直接变化与LOA / MUA的最终需求没有显着相关。预注调VAS和立即发布VAS评分不是最终的LOA / MUA或随后注射的显着预测因子。对于所有3个预测因子,接收器操作员特征曲线下的区域将其分类为极差的鉴别器。结论:对特发性肩粘性囊炎的荧光透视引导胶质环瘤的直接疼痛反应未预测LOA / MUA或随后注射的最终需求。患者可以咨询,即使它们对注射的初始疼痛反应很差,它们仍然具有避免手术的绝佳机会,因为LOA / MUA的总速率低(5.1%)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号